Corinne Hübers

Dr. Corinne Hübers

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CHCorinne Hübers
Corinne Hübers
APAshik Ahmed Abdul Pari
Ashik Ahmed Abdul Pari
DGDenise Grieshober
Denise Grieshober
MPMartin Petkov
Martin Petkov
ASAlexander Schmidt
Alexander Schmidt
MFMoritz Felcht
Moritz Felcht
Primary tumors and distant site metastases form a bidirectionally communicating system. Yet, the molecular mechanisms of this crosstalk are poorly understood. Here, we identified the proteolytically cleaved fragments of angiopoietin-like 4 (ANGPTL4) as contextually active protumorigenic and antitumorigenic contributors in this communication ecosystem. Preclinical studies in multiple tumor models revealed that the C-terminal fragment (cANGPTL4) promoted tumor growth and metastasis. In contrast, the N-terminal fragment of ANGPTL4 (nANGPTL4) inhibited metastasis and enhanced overall survival in a postsurgical metastasis model by inhibiting WNT signaling and reducing vascularity at the metastatic site. Tracing ANGPTL4 and its fragments in tumor patients detected full-length ANGPTL4 primarily in tumor tissues, whereas nANGPTL4 predominated in systemic circulation and correlated inversely with disease progression. The study highlights the spatial context of the proteolytic cleavage-dependent pro- and antitumorigenic functions of ANGPTL4 and identifies and validates nANGPTL4 as a novel biomarker of tumor progression and antimetastatic therapeutic agent.

26 January 2024 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Open access
KYKaan Yilmaz
Kaan Yilmaz
SFSarah Fahimi
Sarah Fahimi
CHCorinne Hübers
Corinne Hübers
CGCyrill Géraud
Cyrill Géraud

13 August 2021 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Closed access
PDF file
CHCorinne Hübers
Corinne Hübers
JBJohannes Benecke
Johannes Benecke
MFMoritz Felcht
Moritz Felcht

7 March 2024 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Open access
KYKaan Yilmaz
Kaan Yilmaz
SFSarah Fahimi
Sarah Fahimi
CHCorinne Hübers
Corinne Hübers
CGCyrill Géraud
Cyrill Géraud

18 November 2026 in Cancers
Verified
Journal Article
Open access
PDF file
CHCorinne Hübers
Corinne Hübers
Jochen UtikalJochen Utikal
Jochen Utikal
SWSebastian Alfred Wohlfeil
Sebastian Alfred Wohlfeil
ISIrina Surovtsova
Irina Surovtsova
COCigdem Oswald
Cigdem Oswald
PMPhilipp Morakis
Philipp Morakis
Background: Pleomorphic dermal sarcoma (PDS) is a rare, cutaneous sarcoma predominantly affecting sun-exposed skin in elderly patients. Surgical excision remains the mainstay of treatment, but evidence on optimal management and long-term outcomes is limited. Methods: We retrospectively analyzed 1069 patients diagnosed with PDS between 2009 and 2025 using data from the Baden-Württemberg Cancer Registry, Germany. Patient characteristics, surgical management, resection status, and preceding malignancies were evaluated. Temporal surgical trends were assessed using multivariable logistic regression. Overall survival (OS) was analyzed using Kaplan–Meier estimates and multivariable Cox regression. Results: Median age was 82 years, and 83.7% of patients were male. The hair-bearing scalp was the most frequent tumor site (55.0%). Among 449 patients with documented surgical procedures, 82.0% underwent micrographically controlled surgery (MGC), with increasing use over time (adjusted OR per year, 1.19; 95% CI, 1.11–1.29). R0-resections were comparable between MGC and conventional resection (75.7% vs. 71.6%). Among 679 patients evaluated for preceding malignancies, 39.7% had a documented cancer history, including 4.4% with hematologic malignancies. Among 723 patients with reliable follow-up, median OS was 72.4 months (95% CI, 61.3–82.1). Mortality was strongly associated with age, but not anatomical tumor site. Surgical approach was not significantly associated with OS after adjustment (MGC vs. conventional resection: HR, 1.49; 95% CI, 0.95–2.3; p = 0.083). Conclusions: This large registry-based study provides real-world evidence on PDS management and prognosis. The increasing adoption of MGC supports its growing role in clinical practice, while the high frequency of preceding malignancies highlights the complex oncological history of patients with PDS.